Under conditions typically encountered in the aquatic environment, the absorption of sunlight by nitrite and nitrate leads to the transformation of trace organic contaminants. In addition to the well understood mechanism through which hydroxyl radical (·OH) produced by nitrate and nitrite photolysis oxidizes contaminants, absorption of light also results in the formation of reactive nitrogen species that transform organic contaminants. To assess the importance of this process on the fate of trace organic contaminants, radical quenchers and transformation product analysis were used to discriminate among potential reaction pathways. For sulfamethoxazole, an antibiotic that is frequently detected in municipal wastewater effluent, nitrate and nitrite-sensitized photolysis pathways resulted in production of transformation products that were not detected during direct photolysis or reaction with ·OH. The reactivity of sulfamethoxazole with the reactive species produced when nitrite absorbed sunlight was affected by the presence of hydroxyl radical scavengers, indicating the likely involvement of nitrogen dioxide, which forms when nitrite reacts with hydroxyl radical. Reactive nitrogen species also reacted with emtricitabine, propranolol, and other trace organic contaminants commonly detected in wastewater effluent, indicating the potential importance of this process to the fate of other trace organic contaminants. A kinetic model indicated that reactive nitrogen species could be important to the phototransformation of trace organic contaminants when relatively high concentrations of nitrite are present (e.g., in surface waters receiving reverse osmosis concentrate from potable water reuse projects or in agricultural runoff).

In shallow, open-water engineered wetlands, design parameters select for a photosynthetic microbial biomat capable of robust pharmaceutical biotransformation, yet the contributions of specific microbial processes remain unclear. Here, we combined genome-resolved metatranscriptomics and oxygen profiling of a field-scale biomat to inform laboratory inhibition microcosms amended with a suite of pharmaceuticals. Our analyses revealed a dynamic surficial layer harboring oxic−anoxic cycling and simultaneous photosynthetic, nitrifying, and denitrifying microbial transcription spanning nine bacterial phyla, with unbinned eukaryotic scaffolds suggesting a dominance of diatoms. In the laboratory, photosynthesis, nitrification, and denitrification were broadly decoupled by incubating oxic and anoxic microcosms in the presence and absence of light and nitrogen cycling enzyme inhibitors. Through combining microcosm inhibition data with field-scale metagenomics, we inferred microbial clades responsible for biotransformation associated with membrane-bound nitrate reductase activity (emtricitabine, trimethoprim, and atenolol), nitrous oxide reduction (trimethoprim), ammonium oxidation (trimethoprim and emtricitabine), and photosynthesis (metoprolol). Monitoring of transformation products of atenolol and emtricitabine confirmed that inhibition was specific to biotransformation and highlighted the value of oscillating redox environments for the further transformation of atenolol acid. Our findings shed light on microbial processes contributing to pharmaceutical biotransformation in open-water wetlands with implications for similar nature-based treatment systems.

Biological treatment of nitrate in reverse osmosis (RO) concentrate produced from municipal wastewater effluent is challenging, in part because of the low carbon-to-nitrogen ratio. Open-water unit process wetlands may provide...